Huberman Lab avatar

Dexa/Huberman Lab

Supported byHuberman Lab
Learn more
Published Jan 19, 2017

Roland Griffiths, Ph.D. on Psilocybin, Psychedelic Therapies & Mystical Experiences

Explore the transformative potential of psilocybin as Roland Griffiths, Ph.D., delves into its therapeutic applications for anxiety and depression, its profound effects on the brain, and the cultural history of psychedelics, offering hope for innovative mental health treatments.
Episode Highlights
Found My Fitness logo

Topics covered

Popular Clips

Questions from this episode

Episode Highlights

  • Cancer Anxiety

    explores the profound impact of psilocybin on anxiety and depression in cancer patients. His research at Johns Hopkins reveals that psilocybin induces mystical experiences, leading to significant and sustained reductions in anxiety and depression, lasting up to six months after a single dose 1. This effect is linked to decreased activity in the brain's Default Mode Network, similar to meditation, which helps patients focus on the present and reduce self-referential processing 2.

    Psilocybin looks very much like meditation in that regard. So there's decreases in the Default Mode Network and that kind of fits with this story.

    ---

    This approach offers hope for improving the quality of life for those facing life-threatening diagnoses 3.

       

    Depression Potential

    Psilocybin's potential in treating depression is gaining attention, with studies showing promising results in treatment-resistant cases. highlights a UK study where psilocybin produced significant, lasting effects in patients with treatment-resistant depression 4. The challenge in such research lies in differentiating between pharmacological effects and expectancy-driven experiences, as the profound changes in consciousness can be influenced by the set and setting 5.

    The power of suggestion is really large, really salient, but it does not account for the extent of the changes that occur with psilocybin.

    ---

    This underscores the need for rigorous methodologies to understand psilocybin's true therapeutic potential.

       

    Safety Concerns

    While psilocybin shows promise, cautions about its risks, emphasizing the importance of controlled settings. His research indicates that psilocybin can lead to significant fear or anxiety, especially without proper support 6. Despite these challenges, the therapeutic benefits, such as reducing activity in the Default Mode Network, are compelling 2.

    We have about 30% of our volunteers who will describe, at least for some duration of time, experiences of significant fear or anxiety come up.

    ---

    Ensuring safe administration and understanding individual vulnerabilities are crucial for maximizing psilocybin's benefits.

Related Episodes